Skip to main content
TipRanks
Go Ultimate75% OFF

BrightSpring Health Services, Inc. (BTSG) AI Stock Analysis

448 Followers
BTSG

BrightSpring Health Services, Inc.

(NASDAQ:BTSG)

Select Model
Rating:72Outperform
Price Target:$74.00▲(3.69% Upside)
Action:reiterated
Date:10/31/26

The score is driven primarily by improving financial performance (profitability recovery and strong free cash flow) and a very upbeat earnings outlook with raised/robust growth guidance. Technicals add support via a positive trend, while the main offset is valuation risk from a high P/E and lack of dividend yield support.

Positive Factors
Growth and OutlookBrightSpring is delivering strong revenue and EBITDA expansion while maintaining ambitious forward guidance. The expected growth, including at least 15%–20% organic adjusted EBITDA growth in 2027, supports continued scale benefits and investment across its healthcare and pharmacy platforms.
Negative Factors
IRA HeadwindThe IRA represents an ongoing reimbursement and revenue pressure on Home and Community Pharmacy rather than a brief quarterly fluctuation. Continued effects could constrain reported growth, require customer and service reprioritization, and weigh on the segment's contribution over the next several quarters.

BrightSpring Health Services, Inc. (BTSG) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%150%BTSG+121.23%SPY+13.31%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$14.20B
Dividend Yield
―
Average Volume (3M)
2.44M
Price to Earnings (P/E)
43.5
Beta (1Y)
1.11
Revenue Growth
22.86%
EPS Growth
157.24%
Country
US
Employees
23,500
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

BrightSpring Health Services, Inc. Business Overview & Revenue Model

Company Description

BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical p...

How the Company Makes Money

BrightSpring primarily makes money by providing healthcare services and pharmacy services that are reimbursed by government programs and other payors. Its revenue model is largely fee-for-service (and, where applicable, contracted reimbursement) acro...

BrightSpring Health Services, Inc. Earnings Call Summary

Earnings Call Date:Oct 30, 2026(Q3-2026)|% Change Since:18.52%|Next Earnings Date:Feb 26, 2027
Earnings Call SentimentPositive

The call was strongly positive, with substantial year-over-year growth in revenue, adjusted EBITDA, EPS, cash flow, specialty pharmacy, provider services, and home health. Management also raised or maintained robust 2026 and 2027 growth expectations, highlighted improving operational metrics, and described broad investment and acquisition opportunities. The principal negative item was the continued IRA-related pressure on Home and Community Pharmacy revenue, along with the limited near-term economic contribution expected from the ACO initiative.

Positive Updates

Strong Companywide Revenue and Profit Growth
Third-quarter revenue was $4.2 billion, up 26% year over year. Adjusted EBITDA was $228 million, up 42%, and adjusted EPS was $0.54, up 80% year over year and 20% sequentially. Gross profit was $519 million, up 32%.

Negative Updates

Home and Community Pharmacy Revenue Declined
Home and Community Pharmacy revenue was $553 million, down 6% year over year. The decline reflected an approximate $50 million impact from the IRA and the decision to exit some uneconomic customers.

Company Guidance

For 2026, excluding the Community Living business and any acquisitions that have not yet closed, total revenue is expected to be in the range of $15.9 billion to $16.125 billion, including pharmacy solutions revenue of $14.0 to $14.2 billion and provider services revenue of $1.9 to $1.93 billion, reflecting 23.2 to 24.9% growth over full year 2025; total adjusted EBITDA is expected to be in the range of $850 million to $860 million, reflecting 37.6 to 39.3% growth over full year 2025, including an expected contribution of approximately $35 million from the Amedisys/LHC asset acquisition, while annual operating cash flow is anticipated to be at least $700 million excluding community living transaction related cash flow impacts, with EBITDA to operating cash conversion of approximately 80% and over $600 million of cash flow after CapEx and before debt pay down and share repurchases; for 2027, the company still expects organic adjusted EBITDA growth of at least 15% to 20%, with year over year adjusted EBITDA growth in each quarter similar to the overall growth for the year and year over year growth in the second half expected to be a little higher than the first half.

BrightSpring Health Services, Inc. Financial Statement Overview

Summary

Financials are improving with a clear profitability turnaround (TTM net income ~$338M) and strong cash generation (TTM operating cash flow ~$603M; free cash flow ~$492M, up ~22%). Balance sheet risk has moderated as equity rebuilt and leverage declined, but leverage remains meaningful (debt-to-equity ~1.17x) and margins are still thin with long-run gross margin compression.

Income Statement

72Positive

Balance Sheet

63Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.25B12.91B11.27B8.83B7.72B6.70B
Gross Profit1.91B1.52B1.59B1.43B1.35B1.25B
EBITDA709.15M459.53M398.13M349.52M391.80M433.34M
Net Income338.34M190.67M-18.06M-154.60M-53.91M49.80M
Balance Sheet
Total Assets6.27B6.41B5.93B5.53B5.44B5.51B
Cash, Cash Equivalents and Short-Term Investments717.84M88.37M61.25M13.07M13.63M46.73M
Total Debt2.38B2.71B2.90B3.67B3.68B3.77B
Total Liabilities4.08B4.53B4.27B4.92B4.66B4.71B
Stockholders Equity2.18B1.88B1.65B584.74M754.78M774.82M
Cash Flow
Free Cash Flow492.41M394.69M-57.14M137.26M-74.77M210.90M
Operating Cash Flow602.74M490.17M23.77M210.78M-4.65M270.17M
Investing Cash Flow462.12M-305.08M-140.24M-134.43M45.36M-1.19B
Financing Cash Flow-488.32M-157.87M164.65M-76.91M-73.81M705.22M

BrightSpring Health Services, Inc. Technical Analysis

Technical Analysis SentimentPositive
Last Price71.37

Price Trends

50DMA62.14Positive
100DMA63.62Positive
200DMA56.35Positive

Market Momentum

MACD2.86Negative
RSI65.15Neutral
STOCH75.77Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BTSG, the sentiment is Positive. The current price of 71.37 is above the 20-day moving average (MA) of 65.84, above the 50-day MA of 62.14, and above the 200-day MA of 56.35, indicating a bullish trend. The MACD of 2.86 indicates Negative momentum. The RSI at 65.15 is Neutral, neither overbought nor oversold. The STOCH value of 75.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BTSG.

BrightSpring Health Services, Inc. Risk Analysis

BrightSpring Health Services, Inc. disclosed 56 risk factors in its most recent earnings report. BrightSpring Health Services, Inc. reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.The sale of our Community Living business may not occur on the terms agreed to by the parties, in the expected time frame, or at all and, as a result, could adversely affect the Company's business and financial condition.Q4, 2024

BrightSpring Health Services, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

BTSG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HNGEHNGE81Outperform$9.86B58.1750.47%―49.86%―
BTSGBTSG72Outperform$14.20B43.5216.75%―22.86%157.24%
OMDAOMDA69Neutral$898.93M60.305.67%―43.34%―
PRVAPRVA59Neutral$3.23B90.124.50%―19.19%84.88%
EVHEVH58Neutral$546.30M-1.07-129.54%―14.06%-189.46%
TDOCTDOC56Neutral$1.59B-10.04-11.63%―-2.38%32.73%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%100%200%BTSGEVHTDOCPRVAHNGEOMDADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
BTSG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
BTSGBrightSpring Health Services, Inc.71.3739.82126.21%
EVHEvolent Health Inc.4.830.8320.75%
TDOCTeladoc Inc.8.701.7024.29%
PRVAPrivia Health Group, Inc.25.262.139.21%
HNGEHinge Health, Inc. Class A121.2980.67198.60%
OMDAOmada Health, Inc.14.49-4.52-23.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026